ELOS Share Price

Open 9.85 Change Price %
High 10.19 1 Day -0.05 -0.51
Low 9.80 1 Week -0.15 -1.50
Close 9.85 1 Month 1.30 15.20
Volume 673533 1 Year 2.62 36.24
52 Week High 10.65
52 Week Low 6.18
ELOS Important Levels
Resistance 2 10.21
Resistance 1 10.06
Pivot 9.95
Support 1 9.64
Support 2 9.49
NASDAQ USA Most Active Stocks
SCHN 26.75 0.38%
SCHN 26.75 0.38%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
DCTH 0.17 6.25%
More..
NASDAQ USA Top Gainers Stocks
LLEN 0.02 100.00%
SPIR 0.02 100.00%
LOCM 0.09 50.00%
GALT 1.94 31.97%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
AEHR 4.99 21.41%
BGMD 0.12 20.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LIWA 0.01 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Syneron Medical Ltd. (NASDAQ: ELOS)

ELOS Technical Analysis 4
As on 21st Feb 2017 ELOS Share Price closed @ 9.85 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.57 & Buy for SHORT-TERM with Stoploss of 8.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
ELOS Target for February
1st Target up-side 10.37
2nd Target up-side 10.94
3rd Target up-side 11.51
1st Target down-side 8.73
2nd Target down-side 8.16
3rd Target down-side 7.59
ELOS Other Details
Segment EQ
Market Capital 321853472.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.syneron.com
ELOS Address
ELOS
Industrial Zone
Tavor Building
Yokneam Illit, 20692
Israel
Phone: 972 73 244 2200
Fax: 972 73 244 2202
ELOS Latest News
Syneron Medical 4Q Loss 3 Cents a Share (ELOS)   Investopedia   - 16th Feb 17
Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full ...   PR Newswire (press release)   - 15th Feb 17
Syneron Medical to Participate in Leerink Partners 6th Annual Global ...   PR Newswire (press release)   - 13th Feb 17
Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million   PR Newswire (press release)   - 09th Nov 16
Syneron Candela Announces FDA Clearance Of Profound™ SubQ To Improve The ...   PR Newswire (press release)   - 08th Nov 16
Syneron Medical Strengthens Senior Management and Announces Preliminary Third ...   PR Newswire (press release)   - 17th Oct 16
Syneron Medical: Staying Patient - And Frustrated   Seeking Alpha   - 09th Sep 16
Syneron Medical to Report Second Quarter 2016 Financial Results on August 4, 2016   PR Newswire (press release)   - 18th Jul 16
Syneron Medical: Q1 Was Enough To Take A Gamble   Seeking Alpha   - 24th Jun 16
Syneron Medical Appoints William Griffing to Newly Created Position of CEO of ...   PR Newswire (press release)   - 12th Feb 15
Interactive Technical Analysis Chart Syneron Medical Ltd. ( ELOS NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Syneron Medical Ltd.
ELOS Business Profile
Syneron Medical Ltd., designs, develops and markets aesthetic medical products based on its various technologies including its Electro-Optical Synergy (ELOS), technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company�s products, which it sells primarily to physicians and other practitioners, target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin�s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference and laser-assisted lipolysis. On February 13, 2012, the Company acquired Ultrashape Ltd. On March 14, 2012, Syneron acquired substantially all the assets of TransPharma Medical Ltd.